Myasthenia Gravis Clinical Trials

254 clinical trials for Myasthenia Gravis across international registries, including 84 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases — RECRUITING · PHASE1
• AXIS MG Patient Registry — RECRUITING
• A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis — RECRUITING · PHASE1
• Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA) — RECRUITING
• MuSK Myasthenia 1000 Study — RECRUITING
• Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis — RECRUITING · PHASE3
• A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis — RECRUITING · PHASE2
• ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod — RECRUITING · PHASE2
• ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis — RECRUITING
• Biomarkers in Autoimmune Disease of Nervous System — RECRUITING
• KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis — RECRUITING · PHASE2
• A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis — RECRUITING · PHASE3
• ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis — RECRUITING · PHASE2
• A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG) — RECRUITING · PHASE2
• Capturing Key MG-symptoms Using Smartphone Recordings. — RECRUITING
• Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis — RECRUITING · PHASE2
• Cohort Study on Neuroimmune Diseases in the Reproductive Age — RECRUITING
• Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis — RECRUITING · PHASE4
• Serum Auto-Antibodies in Neurological Diseases — RECRUITING
• Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases. — RECRUITING · PHASE1
• CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases — RECRUITING · PHASE1
• Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I Short of Breath?" — RECRUITING
• Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases — RECRUITING · PHASE1
• TCM Tongue Diagnosis and Syndrome Differentiation in Myasthenia Gravis Compared to Healthy Controls — RECRUITING · NA
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ROZANOLIXIZUMAB IN ADULT PARTICIPANTS WITH OCULAR MYASTHENIA GRAVIS — RECRUITING · PHASE3
• Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis — RECRUITING · NA
• Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease — RECRUITING · NA
• Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases — RECRUITING · NA
• A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 3 Dose Levels of NMD670 over 21 Days in Adult Patients with AChR/MuSK-Ab+ Myasthenia Gravis — RECRUITING · PHASE2
• A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases — RECRUITING · PHASE1
• A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa — RECRUITING
• Evaluation of the Condition of Patients Receiving EARLY Ravulizumab and Admitted in ICU for gMG Crisis — RECRUITING
• A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding. — RECRUITING
• A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis — RECRUITING · PHASE1
• Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases — RECRUITING · PHASE1
• Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months — RECRUITING
• The EXPLORE MG Registry for Myasthenia Gravis — RECRUITING
• PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry — RECRUITING
• Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis — RECRUITING · PHASE1
• Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders — RECRUITING
• Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis — RECRUITING
• Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology — RECRUITING · NA
• Switching from Off-label & best supportive care to approved therapies for various autoimmune diseases: Implementation, impact on disease progression and adverse events — RECRUITING
• Vitaccess Real MG Registry — RECRUITING
• A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy — RECRUITING · PHASE1
• Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases — RECRUITING · PHASE1
• Application of Artificial Intelligence in Precision Medicine and Healthcare — RECRUITING · NA
• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford — RECRUITING
• Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China — RECRUITING
• The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis — RECRUITING · NA

Refine this search